Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors (Q33366373)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors |
scientific article |
Statements
1 reference
Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors (English)
1 reference
Hiroyuki Kobayashi
1 reference
S Gail Eckhardt
1 reference
Jennifer A Lockridge
1 reference
Mace L Rothenberg
1 reference
Alan B Sandler
1 reference
Cindy L O'Bryant
1 reference
Wendy Cooper
1 reference
Scott N Holden
1 reference
Roger D Aitchison
1 reference
Nassim Usman
1 reference
Maurice Wolin
1 reference
Michele L Basche
1 reference
20 May 2005
1 reference
1 reference
56
1 reference
329-336
1 reference
Identifiers
1 reference
1 reference